Wakely Wire

New Insights

Whitepapers, briefs, press releases and more

Week in Washington 06/18/25

Senate Reconciliation Bill The Senate Finance Committee released legislative text this week. The text included some significant changes from the House Reconciliation bill. A few highlighted changes: Senate Republicans will continue to debate the matter in the coming weeks and changes to the bill are expected. Senate leaders are aiming to have the bill pass ... Read more

Continue reading

Events & More

Adapting for Success in a Changing Healthcare Landscape

Overburdened but Unstoppable: Recharge & Connect with Healthcare Peers in New Orleans

Right now, healthcare professionals everywhere are facing mounting demands—yet they continue to double down on the work that matters. At the HMA National Conference, you’ll join a community that understands the strain, shares your pride in this work, and comes together to lift each other up. Whether you lead policy, operations, clinical programs, or innovation initiatives, you’ll leave with practical tools, fresh inspiration, and a network of colleagues you can draw insights from.

Learn more and register

Newsworthy Findings

HMA Welcomes Matt Allen as New Chief Growth Officer

HMA welcomes Matt Allen as the firm’s first Chief Growth Officer (CGO). He will report to Chief Executive Officer Chuck Milligan and work out of HMA’s Washington, D.C., office. Matt brings more than 25 years of diverse experience in the healthcare sector and a proven track record of advancing growth and innovation to HMA. He will shape the firm’s enterprise-wide growth initiatives, oversee strategic partnerships, and help guide efforts that continue to advance innovation to meet current and emerging client needs.

Read full article
Editor's Note
Prior to joining HMA, Matt was Avalere Health’s practice director and senior vice president of Client Partnerships, and previously held roles in Optum's legacy Advisory Board Company data and analytics practices, at healthcare policy firm Marwood Group, and in Johnson & Johnson's pharmaceutical division.

Iowa Passes Law Imposing Tighter Restrictions on PBMs

Last week, Iowa Gov. Kim Reynolds signed a law seeking to control rising prescription drug costs and protect rural pharmacies.

Read full article
Editor's Note
The law targets what lawmakers describe as the “outsized control” of pharmacy benefit managers (PBMs), aiming to curb patient steering, standardize pharmacy reimbursements, and reform PBM compensation structures. It also mandates that PBMs pass all negotiated rebates from drugmakers directly to health plans. While proponents say the changes will bring transparency and fairness, critics warn the law may unintentionally increase costs for health plans and patients.

Amazon Restructures Healthcare Business

Amazon is reshuffling its various healthcare initiatives into six new divisions, each helmed by a longtime executive or One Medical leader.

Read full article
Editor's Note
Amazon’s track record in healthcare has been mixed. Earlier ventures like Haven and Amazon Care ended quietly after failing to gain traction. More recent efforts—like same-day medication delivery and tools for caregivers—have seen better uptake. This restructuring may be an attempt to bring more structure and accountability to a space where Amazon has struggled to find its footing.

RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’t

Robert F. Kennedy Jr. fired every member of the scientific advisory committee that recommends which vaccines should be given to whom. And he replaced them, in some cases, with vaccine skeptics. Meanwhile, hundreds of employees of the National Institutes of Health sent an open letter to the agency’s director, accusing the Trump administration of policies that “undermine the NIH mission.”

Read full article
Editor's Note
Health and Human Services Secretary Robert F. Kennedy Jr. drew sharp criticism this week after firing all members of a key CDC vaccine advisory panel—despite pledging not to interfere with science-based decisions—and replacing them with individuals, some of whom are vaccine skeptics. Meanwhile, over 300 NIH employees signed a rare public letter of dissent, warning that the administration’s actions are undermining public health and the agency’s mission.

What Are ‘Improper’ Medicaid Payments, and Are They as High as a Trump Official Said?

The vast majority of improper payments stem from documentation mistakes and do not fit the definition of waste, fraud, or abuse. They also typically stem from health care providers’ actions, not beneficiaries’ abuse.

Read full article
Editor's Note
Trump administration officials have claimed that their tax and spending bill targets only Medicaid “waste, fraud, and abuse,” but official government data shows the improper payment rate is around 5%—far below the 16–20% figure cited by budget director Russell Vought. Experts say while the true rate might be higher due to methodological limitations, the administration’s claims significantly exaggerate the problem and misrepresent what improper payments actually entail.

AHIP 2025: A Look at the Current Policy Environment Around Medicare Advantage

Mike Hoak, vice president of public policy at Humana, spoke on a panel about the current state of policy around MA at AHIP 2025 on Monday. He was joined by Elena Tompkins, principal at Tompkins Strategies; Matt Kazan, vice president for policy and government affairs at SCAN Health Plan; and Mark Hamelburg, senior vice president for federal programs at AHIP.

Read full article
Editor's Note
With Medicare Advantage now covering more than half of all Medicare eligibles, the program is receiving scrutiny at a time when policy makers are needing to cut costs.

Bonus Article

Just for Fun

Math Joke:

Why did the girl wear glasses during math class?

Prior Week

Why did the geometry teacher eat pizza? Because he wanted some pi!

Sign up for the
Wakely Wire,

our industry newsletter.